Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Immunity care has become a major part of people’s hectic lifestyle, as consumers are increasingly concerned about their health system.
There are various immune health supplement such as vitamin A, vitamin B2, vitamin B6, and vitamin C, which are used to increase immunity. Vitamin D is a fat-soluble nutrient essential to the health and functioning of your immune system.
Immune Health Supplements Market - Impact of Coronavirus (Covid-19) Pandemic
The coronavirus (COVID 19) pandemic and lockdown in various countries across the globe have impacted the financial status of business in all sectors. Private healthcare sector is one the sectors, which is majorly impacted by the COVID 19 pandemic.
The lockdown in various countries due to the COVID 19 pandemic has created economic burden on the private healthcare sectors
Healthcare providers were facing problem in investing additional manpower, equipment, consumables, and other resources to ensure safety in hospitals, to provide treatment to the patients with other diseases, and declining outpatients visits, etc.
Moreover, coronavirus pandemic has negatively impacted the development, production, and supply of Immune Health Supplements and affected growth of the healthcare businesses of various companies across the globe, as COVID 19 pandemic has lead to unprecedented lockdown in several countries, globally. This lockdown has resulted in closure of industrial establishments, except manufacturing of essential commodities and disruption in supply chain of the products
The global immune health supplements market is estimated to be valued at US$ 14,913.8 million in 2020 and is expected to exhibit a CAGR of 6.1% during the forecast period (2020-2027).
Figure 1. Immune Health Supplements Market Share (%) Analysis, By Region, 2020
The increasing prevalence of chronic diseases and rising ageing population across the globe are expected to drive the global immune health supplements market growth.
Rising prevalence of chronic diseases is expected to be a major reason for growth of the overall market during the forecast period. The changing lifestyle disorder across the globe is expected to increase demand for immune health supplements. For instance, according to the National Center for Biotechnology Information 2018 report, globally, approximately one in three of all adults suffer from multiple chronic conditions (MCCs).
Furthermore, according to World Population Prospects, in 2017, the global geriatric population was around 962 million, which is expected to reach around 2.1 billion by 2050.
Immune Health Supplements Market– Restraints
Immune health supplements have side-effects and risks, as it is self-prescribed and have lots of wrong information, which is expected to hinder the market growth. For instance, people seeking weight loss supplements may face problems associated with the liver. Hence, supplements have other side-effects as well and this factor is expected to restrict the market growth of health immune supplements.
Moreover, lack of awareness regarding health immune supplements across emerging economies is expected to restrict the market growth over the forecast period.
Immune Health Supplements Market Report Coverage
| Report Coverage |
Details |
| Base Year: |
2019 |
Market Size in 2019: |
US$ 14,913.8 Mn |
| Historical Data for: |
2016 to 2019 |
Forecast Period: |
2020 to 2027 |
| Forecast Period 2020 to 2027 CAGR: |
6.1% |
2027 Value Projection: |
US$ 22,702.4 Mn |
| Geographies covered: |
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
|
| Segments covered: |
- By Ingredients: Vitamins, Omega 3 fatty Acids, Probiotics, Minerals, Others (amino acids, herbal and botanical extract).
- By source: Plant-based, Animal-based.
- By Form: Tablets, Capsules, Powder, Liquid.
- By Distribution Channel: Hypermarkets/Supermarkets, Retail Pharmacies, Online Pharmacies.
|
| Companies covered: |
EuroPharma, Inc., Glanbia, Plc., Bio Tech Pharmacal, Cellderm Technologies Inc., Bayer AG, Vital Nutrients, NutriGold Inc., Daflorn Ltd., BioGaia, and Seroyal
|
| Growth Drivers: |
- The increasing prevalence of chronic diseases and rising ageing population across the globe
|
| Restraints & Challenges: |
- Side effect of immune health supplement
|
Immune Health Supplements Market– Regional Analysis
North America accounted for the largest share in the immune health supplements market in 2019, as key players in the region are focusing on strategies such as mergers & acquisitions, product innovation, joint ventures, collaborations, and partnership to enhance their market position. For instance, in 2019, Herbalife Nutrition Ltd. introduced a new immune supplement ‘EpiCor’ for busy Americans to help them stay healthy. This essential immunity line contains key micronutrients and multivitamins that support and strengthen the immune system with vitamin D, zinc, and antioxidants.
Furthermore, Asia Pacific is expected to witness the fastest growth during the forecast period, owing to increasing geriatric population in Asia Pacific and demand for immune health supplements as it serves as a preventive measure. For instance, according to the United Nations Population Fund, the population of older persons (aged over 60) in the Asia Pacific region is expected to triple between 2010 and 2050, and reach close to 1.3 billion.
Figure 2. Immune Health Supplements Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027
Immune Health Supplements Market- Competitive Landscape
Key players operating in the immune health supplements market include EuroPharma, Inc., Glanbia, Plc., Bio Tech Pharmacal, Cellderm Technologies Inc., Bayer AG, Vital Nutrients, NutriGold Inc., Daflorn Ltd., BioGaia, and Seroyal.
US :
INDIA :
UK :
JAPAN :
U.S. :
+1-206-701-6702
UK :
+44-020-8133-4027
JAPAN :
+81-50-5539-1737
INDIA :
+91-848-285-0837
Sales Office (U.S.) : 
